Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

ProPhase Labs, Inc.

CIK 868278 PRPH·Pharmaceutical Preparations · All EDGAR filings ↗

Progression

  1. Late filing NT 10-K
  2. Going concern 10-K +66d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing elevated Filing comparison

ProPhase Labs, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date. other reports also outstanding

(the “Company”) is unable, without unreasonable effort or expense, to timely file its Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2026. The delay in filing is primarily due to the additional time required to complete the Company’s review procedures performed by the Company’s independent registered public accounting firm. The Company is working diligently with its auditors to finalize the financial statements and related disclosures.
Evidence
Anticipates significant change
No
Days past due date
0
Other periodic reports filed
No
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable, without unreasonable effort or expense, to timely file its Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2026. The delay in filing is primarily due to the additional time required to complete the Company’s review procedures performed by the Company’s independent registered public accounting firm. The Company is working diligently with its auditors to finalize the financial statements and related disclosures.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Going concern Filing comparison

ProPhase Labs, Inc. said management's plans alleviate substantial doubt about going concern

No going-concern disclosure → Substantial doubt raised, alleviated by management's plans

Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As of March 31, 2026, the Company had minimal cash resources and a significant working capital deficit. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. Management’s plans do not alleviate this substantial doubt. Management has evaluated the significance of these conditions and has developed plans intended to improve liquidity and support…
Evidence
Blank check
No
Comparable
Yes
Current state
doubt_alleviated
Current state label
Substantial doubt raised, alleviated by management's plans
Direction
escalated
Located in
going-concern note
Prior filed
2025-11-19
Prior form
10-Q
Prior state
none
Prior state label
No going-concern disclosure
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.

Source filing ↗ Prior filing ↗

Going concern Filing comparison

ProPhase Labs, Inc. disclosed substantial doubt about its ability to continue as a going concern

No going-concern disclosure → Substantial doubt about ability to continue as a going concern

The outcome, timing, and amount of any recovery from the receivables collection program and the operational reorganization are uncertain and subject to factors outside the Company’s control, including Bankruptcy Court approval, payor responses to claims, the development and confirmation of a plan, and the priority scheme of the Bankruptcy Code. These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements included in this Annual Report are issued. The Company’s ability to continue as a going…
Evidence
Blank check
No
Comparable
Yes
Current state
substantial_doubt
Current state label
Substantial doubt about ability to continue as a going concern
Direction
escalated
Located in
going-concern note
Prior filed
2025-04-30
Prior form
10-K/A
Prior state
none
Prior state label
No going-concern disclosure
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.

Source filing ↗ Prior filing ↗

Late filing elevated Filing comparison

ProPhase Labs, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date. other reports also outstanding

(the “Company”) is unable, without unreasonable effort or expense, to timely file its Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2026. The delay in filing is primarily due to the additional time required to complete the Company’s year-end financial reporting process and its Annual Report on Form 10-K, including the completion of the ongoing audit procedures performed by the Company’s independent registered public accounting firm. The Company is working diligently with its auditors to finalize the financial statements and related disclosures and will be filed following the Annual Report on Form 10-K when the Audit for the year ended December 31, 2025 is completed.
Evidence
Anticipates significant change
No
Days past due date
0
Other periodic reports filed
No
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable, without unreasonable effort or expense, to timely file its Quarterly Report on Form 10-Q for the Quarter Ended March 31, 2026. The delay in filing is primarily due to the additional time required to complete the Company’s year-end financial reporting process and its Annual Report on Form 10-K, including the completion of the ongoing audit procedures performed by the Company’s independent registered public accounting firm. The Company is working diligently with its auditors to finalize the financial statements and related disclosures and will be filed following the Annual Report on Form 10-K when the Audit for the year ended December 31, 2025 is completed.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing elevated Filing comparison

ProPhase Labs, Inc. told the SEC it could not file its annual report on time

Does not expect a significant change in results. Filed 4 days before the statutory due date.

(the “Company”) is unable, without unreasonable effort or expense, to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The delay in filing is primarily due to the additional time required to complete the Company’s year-end financial reporting process, including the completion of the Company’s income tax provision and the ongoing audit procedures performed by the Company’s independent registered public accounting firm.
Evidence
Anticipates significant change
No
Days past due date
-4
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable, without unreasonable effort or expense, to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The delay in filing is primarily due to the additional time required to complete the Company’s year-end financial reporting process, including the completion of the Company’s income tax provision and the ongoing audit procedures performed by the Company’s independent registered public accounting firm.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗